Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-047942

Chief Medical Officer sold 12,500 shares at an average $50.95 ($636,855)

  • Chief Medical Officer acquired 26,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pang Phillip · Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-19 Exercise or conversion : show line 1 in the form +10,185 $1.58 $16,041 25,962 D
2020-08-19 Exercise or conversion : show line 2 in the form +2,315 $5.18 $11,980 28,277 D
2020-08-19 Exercise or conversion : show line 3 in the form +14,000 $0.86 $11,970 42,277 D
2020-08-19 Sale : show line 4 in the form −5,000 $50.96 $254,808 37,277 D
2020-08-19 Sale : show line 5 in the form −7,500 $50.94 $382,048 29,777 D
Open-market sales · 12,500 sh · avg $50.95 · $636,855

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-08-19 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) −10,185 75,462 D
2020-08-19 Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) −2,315 71,759 D
2020-08-19 Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) −14,000 81,333 D
Loading xslF345X03/doc4.xml…